These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32633703)

  • 1. Occupational exposure of pharmacy technicians and cleaning staff to cytotoxic drugs in Dutch hospitals.
    Crul M; Hilhorst S; Breukels O; Bouman-d'Onofrio JRC; Stubbs P; van Rooij JG
    J Occup Environ Hyg; 2020; 17(7-8):343-352. PubMed ID: 32633703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study.
    Fransman W; Vermeulen R; Kromhout H
    Ann Occup Hyg; 2004 Apr; 48(3):237-44. PubMed ID: 15059800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities.
    Fransman W; Vermeulen R; Kromhout H
    Int Arch Occup Environ Health; 2005 Jun; 78(5):403-12. PubMed ID: 15887018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?
    Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
    Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
    J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide.
    Sugiura S; Asano M; Kinoshita K; Tanimura M; Nabeshima T
    J Oncol Pharm Pract; 2011 Mar; 17(1):14-9. PubMed ID: 20179165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia from dermal exposure to cyclophosphamide among nurses in The Netherlands: quantitative assessment of the risk.
    Fransman W; Kager H; Meijster T; Heederik D; Kromhout H; Portengen L; Blaauboer BJ
    Ann Occup Hyg; 2014 Apr; 58(3):271-82. PubMed ID: 24412718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents.
    Sessink PJ; Cerná M; Rössner P; Pastorková A; Bavarová H; Franková K; Anzion RB; Bos RP
    Mutat Res; 1994 Sep; 309(2):193-9. PubMed ID: 7520976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.
    Wick C; Slawson MH; Jorgenson JA; Tyler LS
    Am J Health Syst Pharm; 2003 Nov; 60(22):2314-20. PubMed ID: 14652980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?
    Sessink PJ; Van de Kerkhof MC; Anzion RB; Noordhoek J; Bos RP
    Arch Environ Health; 1994; 49(3):165-9. PubMed ID: 8185386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous training program for technicians handling antineoplastic drugs and occupational exposure risk].
    Dussart C; Favier B; Gilles L; Camal I; Almeras D; Latour JF; Grelaud G
    Bull Cancer; 2008 Sep; 95(9):821-2. PubMed ID: 18829414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
    Clark BA; Sessink PJ
    J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of antineoplastic agents in pharmacy personnel. Part II: study of work-related risk factors.
    Schreiber C; Radon K; Pethran A; Schierl R; Hauff K; Grimm CH; Boos KS; Nowak D
    Int Arch Occup Environ Health; 2003 Feb; 76(1):11-6. PubMed ID: 12592577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study of environmental contamination with antineoplastic drugs in 36 Canadian hospitals: a 2013 follow-up study.
    Berruyer M; Tanguay C; Caron NJ; Lefebvre M; Bussières JF
    J Occup Environ Hyg; 2015; 12(2):87-94. PubMed ID: 25105559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals.
    Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N
    Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to antineoplastic drugs in two UK hospital pharmacy units.
    Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ
    Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production.
    Werumeus Buning A; Geersing TH; Crul M
    Int J Pharm Pract; 2020 Feb; 28(1):66-74. PubMed ID: 31489970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.